TST808

TST808 is a humanized antibody neutralizing one of the validated key targets regulating B/plasma cell proliferation and survival. TST808 has improved properties in blocking B cell proliferation and signalling. It has extended half-life as well. TST808 has the potential to treat multiple autoimmune renal disorders including IgAN.